transcription-profiling-of-mouse-e-myc-model-for-l060b-cell lymphomacellgenomelymphlymphomamedianspleenmouseFalseE-GEOD-78977853Transcription profiling of mouse E-myc model for lymphomatranscription-profiling-of-mouse-spleen-from-anima057celldiseasegenomemedianpointproteinspleenmouseFalseE-GEOD-175095779Transcription profiling of mouse spleen from animals exposed to Ebola virus reveals reduced levels of protein tyrosine phosphatase CD45 protect mice from the lethal effects of Ebola virus infectionidentification-and-validation-of-a-multigene-predi5109cancercarcinomadiseaselaryngeal carcinomamedianpointhumanFalseE-GEOD-270201212Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.transcriptional-effects-of-ctgf-inhibition-and-gem224adenocarcinomacellductal adenocarcinomamedianpancreatic ductal adenocarcinomaproteinmouseFalseE-GEOD-462038699Transcriptional effects of CTGF inhibition and gemcitabine in the KPC mouse model of pancreatic ductal adenocarcinomaa-clinically-relevant-gene-signature-in-triple-neg067basalbreastbreast cancercancercelldiseaselinemedianstromahumanFalseE-GEOD-3151910008A Clinically Relevant Gene Signature in Triple-Negative and Basal-Like Breast Cancerexpression-of-vav1-in-glioblastoma-multiforme332astrocytecancercellcentromerechromosomeclassglioblastoma multiformegliomamedianpalmserumhumanFalseE-GEOD-240721336EXPRESSION OF VAV1 IN GLIOBLASTOMA MULTIFORMEtranscription-profiling-of-human-conjunctival-epit016cellconjunctivaconjunctival epithelial celldiseaseepithelial celllipidmedianproteinpterygiumsurfacehumanFalseE-GEOD-86331553Transcription profiling of human conjunctival epithelial cell linestranscription-profiling-of-human-wilms-tumor-sampl0144centraleyemedianhumanFalseE-GEOD-103201462Transcription profiling of human Wilms tumor samples to predicting relapse in favorable histology casesvalidation-cohort-for-genomic-predictor-of-respons11198breastbreast cancercancerdiseaseestrogenmedianhumanFalseE-GEOD-250651317Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer